Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjogrens syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
This product is not intended for human consumption, therapeutic applications, veterinary use, diagnostic procedures, cosmetic use, or clinical applications of any kind
Wish you all the best
Indian company Biocon has already agreed a semaglutide licensing and supply deal in Brazil with Biomm SA
US$ 29.77
US$ 23.63
US$ 29.78
US$ 21.30
US$ 21.17
US$ 24.78
US$ 22.89
US$ 26.04
US$ 27.67
US$ 25.31
